Competing Policy Windows in Biotechnology: The FDA, the 21st Century Cures Act, and Laboratory‐Developed Tests (Pages 89-119)

by

Competing Policy Windows in Biotechnology: The FDA, the 21st Century Cures Act, and Laboratory‐Developed Tests
Nathan Myers Catherine E. Steding Peter Mikolaj

https://doi.org/10.1111/ropr.12262